MIDODRINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Midodrine Hydrochloride, and what generic alternatives are available?
Midodrine Hydrochloride is a drug marketed by Alembic, Apotex, Aurobindo Pharma Ltd, Chartwell Rx, Endo Operations, Impax Pharms, Mankind Pharma, Mylan Pharms Inc, Novugen, Rubicon, Thinq Pharm-cro Pvt, Xiromed, and Zydus Lifesciences. and is included in thirteen NDAs.
The generic ingredient in MIDODRINE HYDROCHLORIDE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Midodrine Hydrochloride
A generic version of MIDODRINE HYDROCHLORIDE was approved as midodrine hydrochloride by MYLAN PHARMS INC on September 10th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MIDODRINE HYDROCHLORIDE?
- What are the global sales for MIDODRINE HYDROCHLORIDE?
- What is Average Wholesale Price for MIDODRINE HYDROCHLORIDE?
Summary for MIDODRINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 13 |
| Finished Product Suppliers / Packagers: | 26 |
| Raw Ingredient (Bulk) Api Vendors: | 87 |
| Clinical Trials: | 100 |
| Patent Applications: | 285 |
| DailyMed Link: | MIDODRINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MIDODRINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Noha Mansour | Phase 4 |
| RenJi Hospital | N/A |
| Fuwai Yunnan Cardiovascular Hospital | N/A |
Pharmacology for MIDODRINE HYDROCHLORIDE
| Drug Class | alpha-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists |
Medical Subject Heading (MeSH) Categories for MIDODRINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MIDODRINE HYDROCHLORIDE
US Patents and Regulatory Information for MIDODRINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thinq Pharm-cro Pvt | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 207613-002 | Nov 2, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rubicon | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 212543-001 | Aug 19, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Thinq Pharm-cro Pvt | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 207613-003 | Nov 2, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rubicon | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 212543-002 | Aug 19, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alembic | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 214734-001 | Jan 21, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Impax Pharms | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 076449-003 | Dec 16, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
